EviCure Ltd.
Biomed — Stage: R&D. Est: 2023. Tags: Artificial Intelligence, Biotechnology, Cancer, Healthtech, Life Sciences, MedTech, Oncology, Pharmaceuticals. EviCure is a developer of extracellular vesicle-based platform technology for cancer treatment. The company's platform utilizes AI and human cancer models to design EVs loaded with therapeutic molecules or inherent anti-tumor properties, targeting multiple cancer types and potentially overcoming treatment resistance, providing patients with a safe, cost-effective, mutation-agnostic, and stage-independent treatment. EviCure has also developed an approach for scale-up of EVs, using artificial intelligence algorithms and biological sensors to produce EVs consistently and reproducibly while maintaining their anti-tumor effects throughout the entire scale-up production.. Web: https://www.evicure.bio